BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
IMUC signs option agreement with MD Anderson Cancer Center
-
UTSA adopts Click Commerce’s research, compliance software
-
Sole Finalist Named for UTPA President Position
-
Collaboration creates 250 jobs in Richardson
-
Tech research at UT in line for $2M in funding
-
University of Texas at Dallas receives 16 gifts worth more than $16.8M
-
RF Code Announces First Ever Wire-Free Liquid Detection Sensor
-
In the race to turn back the biological clock, consumers are reaching for an unproven...
-
TerraTherm, Inc.: TerraTherm Royalty Payments to The University of Texas at Austin Top $1 Million...
News & Analysis
Filter by
dallas and patent and university of texas - All News and Analysis
University of Texas patents anti-hair loss treatment
* Patent No. US 6,680,344 B1: The University of Texas Southwestern Medical Center, Dallas, TX, patented a hair loss treatment method using a cardiac-sparing compound, pharmaceutically acceptable salts, hydrates, biohydrolyzable amides, esters and imides. They are administered to the scalp.
U. of Texas affiliate patents hair loss treatment
* Patent No. US 6,646,005 B1: The University of Texas Southwestern Medical Center, Dallas, TX, patented a method to treat hair loss comprising the administration of a cardiac-sparing compound and pharmaceutically acceptable salts, hydrates and biohydrolyzable amides, esters and imides.
University of Texas Southwestern Medical Center and Regeneron receive U.S. patent covering MAP kinase
DALLAS, Texas/TARRYTOWN, New York--BW HealthWire--April 4, 1997--Enzyme recently shown to be hyperexpressed in breast cancerThe University of Texas Southwestern Medical Center at Dallas and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that they have received U.S. Patent No. 5,595,904 entitled "Family of MAP2 Protein Kinases." MAP kinases are intracellular enzymes...
- 1


